Essentium, Inc., announced it has collaborated with Vorum, a world leader in CAD/CAM solutions for the global O&P market, to introduce a line of biocompatible 3D printing materials. The new materials meet ISO 10993 and US FDA guidance for intact skin surface devices as verified by certified, independent lab testing. A study co-commissioned by Essentium and Vorum verified that Essentium’s PCTG, PA-CF, TPU 74D, and PET-CF are non-contact sensitive, non-cytotoxic, and non-irritant, enabling O&P clinicians to use the 3D printing materials for O&P devices that require long-term skin contact.
Advancements in 3D printing platforms and software allow O&P clinicians to design and create bespoke lightweight, functional, and affordable devices for patients. They can do it more quickly and efficiently than traditional methods. This has increased the demand for biocompatible 3D printing materials to ensure the long-lasting comfort of O&P devices.
Biocompatible materials are crucial for O&P patients who need to wear devices that contact their skin for long periods. Essentium’s next-generation materials unlock important advances for O&P devices, such as lightweight prosthetic sockets that provide reliable strength and long-lasting comfort.
The Essentium and Vorum partnership brings together the Essentium High-Speed Extrusion (HSETM) 3D Printing Platform and biocompatible materials with Vorum’s O&P CAD/CAM solutions and SurePathTM methodology. With 30 years of experience in O&P digital processes, Vorum developed SurePathTM to provide O&P clinicians with a proven approach for 3D printing adoption, implementation, training, and support. This partnership enables O&P practitioners to make a swift and successful transition from plaster-casting methods to 3D printing in any O&P production setting.